Zimmer Biomet Holdings, INC Form 4 insider transactions

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and conversion of restricted stock units into common stock.

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., acquired 2,458 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the acquisition of 7,040 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Mark Bezjak, President of Americas at Zimmer Biomet, reports acquisition of restricted stock units.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., acquired 8,352 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Wilfred van Zuilen, Group President, EMEA of Zimmer Biomet Holdings, Inc., reports the acquisition of 9,545 restricted stock units.

Suketu Upadhyay, Exec. VP and CFO of Zimmer Biomet Holdings, Inc., reports the acquisition of 19,090 restricted stock units on February 25, 2025, according to a Form 4 filing with the SEC.

Zimmer Biomet's CEO, Ivan Tornos, reports the acquisition of restricted stock units in the company.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the acquisition of 7,875 restricted stock units on February 25, 2025, vesting annually over three years.

Mark Bezjak, President, Americas at Zimmer Biomet, reports the vesting of restricted stock units and subsequent share withholding for tax obligations.

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and associated tax withholding.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent stock transactions.

Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related transactions.

Zimmer Biomet's CEO, Ivan Tornos, reports the vesting and subsequent sale of shares to cover tax obligations related to restricted stock units.

Executive VP and CFO of Zimmer Biomet Holdings, Suketu Upadhyay, reports the vesting of restricted stock units and subsequent tax withholding.

Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent transactions involving common stock.

Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units.

Sang Yi, Group President of Asia Pacific at Zimmer Biomet, reports the acquisition and vesting of restricted stock units and shares acquired through employee stock purchase and dividend reinvestment.

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units (RSUs) and subsequent transactions involving common stock.

Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports acquisition and disposal of common stock and restricted stock units.

CEO Ivan Tornos reports acquisition and disposal of Zimmer Biomet stock and restricted stock units.

Executive VP and CFO of Zimmer Biomet, Suketu Upadhyay, reports acquisition and disposal of common stock and restricted stock units.

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports acquisition and disposal of common stock and restricted stock units.

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting and subsequent disposition of restricted stock units and other stock transactions.

Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet, reports the vesting and subsequent transactions involving restricted stock units and common stock.

Director Devdatt Kurdikar reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Director Kolli Sreelakshmi reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.